NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) Reference number Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 -...
Buyer
NHS England
Value
£31,584,025
Published
25 Jan 2023
Closes
21 Feb 2023
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection
£31,584,025
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) Reference number Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) fo...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
17 Jan 2023
Opportunity notice on Contracts Finder
Tender notice · Web page
Document No. 00 - Read Me First Document
Not provided
Document No. 00 - Read Me First Document
Word document
Document No. 01 - Invitation to offer covering letter
Not provided
Document No. 01 - Invitation to offer covering letter
Word document
Document No. 02 - Terms of offer
Not provided
Document No. 02 - Terms of offer
Word document
Document No. 03 - Framework Agreement and Terms and Conditions
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions
Document No. 05a(iv) CM_PHG_22_5694_01
Not provided
Document No. 05a(iv) CM_PHG_22_5694_01
XML
Document No. 05b - Selectt offer schedule instructions
Not provided
Document No. 05b - Selectt offer schedule instructions
Word document
Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022
Not provided
Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022
Document No. 08 - Confidential information schedule
Not provided
Document No. 08 - Confidential information schedule
Excel spreadsheet
Document No. 04a - Quality Assurance Process
Not provided
Document No. 04a - Quality Assurance Process
Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements
Not provided
Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements
Document No. 05a(i) - Tender Product Listing and Usage - Dasatinib
Not provided
Document No. 05a(i) - Tender Product Listing and Usage - Dasatinib
Excel spreadsheet
Contains public sector information licensed under the Open Government Licence v3.0.